Related Experiment Video
Updated: Jan 20, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
Dengue Virus M Protein Promotes NLRP3 Inflammasome Activation To Induce Vascular Leakage in Mice
Pan Pan1, Qi Zhang1, Weiyong Liu1
1State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.
Abstract:
Dengue virus (DENV) infection causes serious clinical symptoms, including dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Vascular permeability change is the main feature of the diseases, and the abnormal expression of proinflammatory cytokines is the important cause of vascular permeability change. However, the mechanism underlying vascular permeability induced by DENV has not been fully elucidated. Here, we reveal a distinct mechanism by which DENV infection promotes NLRP3 inflammasome activation and interleukin-1 beta (IL-1β) release to induce endothelial permeability and vascular leakage in mice. DENV M protein interacts with NLRP3 to facilitate NLRP3 inflammasome assembly and activation, which induce proinflammatory cytokine IL-1β activation and release. Notably, M can induce vascular leakage in mouse tissues by activating the NLRP3 inflammasome and IL-1β. More importantly, inflammatory cell infiltration and tissue injuries are induced by M in wild-type (WT) mouse tissues, but they are not affected by M in NLRP3 knockout (NLRP3-/-) mouse tissues. Evans blue intensities in WT mouse tissues are significantly higher than in NLRP3-/- mouse tissues, demonstrating an essential role of NLRP3 in M-induced vascular leakages in mice. Therefore, we propose that upon DENV infection, M interacts with NLRP3 to facilitate inflammasome activation and IL-1β secretion, which lead to the induction of endothelial permeability and vascular leakage in mouse tissues. The important role of the DENV-M-NLRP3-IL-1β axis in the induction of vascular leakage provides new insights into the mechanisms underlying DENV pathogenesis and DENV-associated DHF and DSS development.IMPORTANCE Dengue virus (DENV) is a mosquito-borne pathogen, and infections by this virus are prevalent in over 100 tropical and subtropical countries or regions, with approximately 2.5 billion people at risk. DENV infection induces a spectrum of clinical symptoms, ranging from classical dengue fever (DF) to severe dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Therefore, it is important to understand the mechanisms underlying DENV pathogenesis. In this study, we reveal that the DENV membrane protein (M) interacts with the host NLRP3 protein to promote NLRP3 inflammasome activation, which leads to the activation and release of a proinflammatory cytokine, interleukin-1 beta (IL-1β). More importantly, we demonstrate that M protein can induce vascular permeability and vascular leakage and that NLRP3 is required for M-induced vascular leakage in mouse tissues. Collectively, this study reveals a distinct mechanism underlying DENV pathogeneses and provides new insights into the development of therapeutic agents for DENV-associated diseases.
Insights
Dengue virus (DENV) M protein activates the NLRP3 inflammasome, releasing IL-1β. This process increases vascular permeability and leakage, contributing to severe dengue symptoms like DHF and DSS.
Area of Science:
- Virology and Immunology
- Molecular Biology
- Pathogenesis Research
Background:
- Dengue virus (DENV) infection can lead to severe clinical manifestations such as dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).
- Increased vascular permeability is a hallmark of severe dengue, driven by proinflammatory cytokines, but the precise mechanisms remain incompletely understood.
- Understanding DENV pathogenesis is crucial for developing effective treatments against this widespread mosquito-borne viral disease.
Purpose of the Study:
- To elucidate the mechanism by which DENV induces endothelial permeability and vascular leakage.
- To investigate the role of the DENV M protein and the NLRP3 inflammasome in DENV pathogenesis.
- To identify potential therapeutic targets for DENV-associated severe disease.
Main Methods:
- Investigated the interaction between DENV M protein and NLRP3 in mouse models.
- Assessed the activation of the NLRP3 inflammasome and release of IL-1β upon DENV infection.
- Quantified vascular leakage using Evans blue dye in wild-type and NLRP3 knockout mice.
Main Results:
- DENV M protein directly interacts with NLRP3, promoting inflammasome assembly and activation.
- NLRP3 inflammasome activation leads to the release of interleukin-1 beta (IL-1β), a key proinflammatory cytokine.
- M protein-induced vascular leakage and tissue injury in mice are dependent on NLRP3 activation.
Conclusions:
- The DENV M-NLRP3-IL-1β axis is a critical pathway mediating endothelial permeability and vascular leakage.
- NLRP3 inflammasome activation plays a significant role in the pathogenesis of DENV-associated vascular complications.
- This study provides novel insights into DENV pathogenesis, highlighting a potential therapeutic target for DHF and DSS.
Related Concept Videos
What are Viruses?
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Activation and Inactivation of G Proteins
Seedless Vascular Plants
Co-activators and Co-repressors

